Cargando…
Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide
Pulmonary arterial hypertension (PAH) associated with systemic lupus erythematosus (SLE) or mixed connective tissue disease (MTCD), in contrast to other types of PAH, may respond to immunosuppressive therapy. Most PAH cases with an immunosuppressant response were in the early stages of the disease (...
Autores principales: | Sugawara, Eri, Kato, Masaru, Hisada, Ryo, Oku, Kenji, Bohgaki, Toshiyuki, Horita, Tetsuya, Yasuda, Shinsuke, Atsumi, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364200/ https://www.ncbi.nlm.nih.gov/pubmed/28202869 |
Ejemplares similares
-
Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysis
por: Ohmura, Kazumasa, et al.
Publicado: (2018) -
Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension: A cross-sectional study
por: Nakamura, Hiroyuki, et al.
Publicado: (2017) -
Plasma gelsolin facilitates interaction between β(2) glycoprotein I and α(5)β(1) integrin
por: Bohgaki, Miyuki, et al.
Publicado: (2011) -
Successful treatment with tacrolimus of refractory adult-onset Still's disease
por: Ohe, Masashi, et al.
Publicado: (2014) -
Efficacy and safety of oral pulmonary vasodilators in pulmonary veno‐occlusive disease
por: Nakamura, Junichi, et al.
Publicado: (2022)